99199728
May 23, 2025
Pharmaceutical preparations, namely, single-administration gene therapies for the treatment and long-term management of chronic diseases; genetic therapies for medical purposes; therapeutic preparations comprising viral vectors for gene delivery; biopharmaceuticals for modifying genetic expression to treat chronic or inherited conditions; injectable gene therapy products for use in treating metabolic, autoimmune, cardiovascular, or neurological disorders; biologics in the nature of pharmaceutical preparations for the treatment of chronic diseases and metabolic, autoimmune, cardiovascular, or neurological disorders; Biological preparations for the prevention or treatment of chronic diseases and metabolic, autoimmune, cardiovascular, or neurological disorders; Injectable pharmaceutical preparations for treatment of chronic diseases and metabolic, autoimmune, cardiovascular, or neurological disorders; long-duration medicines for treatment of chronic diseases and metabolic, autoimmune, cardiovascular, or neurological disorders
Pharmaceuticals